Objective: Hypocalcemia is an important metabolic disease of dairy cows during the transition period, although the effect of hypocalcemia on biological function in dairy cows remains unknown. Methods: In this study, proteomic, mass spectrum, bioinformatics and western blotting were employed to identify differentially expressed proteins related to serum Ca concentration. Serum samples from dairy cows were collected at three time points: 3rd days before calving (day -3), the day of calving (day 0), and 3rd days after calving (day +3). According to the Ca concentration on day 0, a total of 27 dairy cows were assigned to one of three groups (clinical, subclinical, and healthy). Samples collected on day -3 were used for discovery of differentially expressed proteins, which were separated and identified via proteomic analysis and mass spectrometry. Bioinfor matics analysis was performed to determine the function of the identified proteins (gene ontology and pathway analysis). The differentially expressed proteins were verified by western blot analysis. Results: There were 57 differential spots separated and eight different proteins were identified. Vitamin Dbinding protein precursor (groupspecific component, GC), alpha2macroglobulin (A2M) protein, and apolipoprotein AIV were related to hypocalcemia by bioinformatics analysis. Due to its specific expression (upregulated in clinical hypocalcemia and downregulated in subclinical hypocalcemia), A2M was selected for validation. The results were consistent with those of proteomic analysis. Conclusion: A2M was as an early detection index for distinguishing clinical and subclinical hypocalcemia. The possible pathogenesis of clinical hypocalcemia caused by GC and apolipo protein AIV was speculated. The downregulated expression of GC was a probable cause of the decrease in calcium concentration.
INTRODUCTION
Hypocalcemia is an important nutritional metabolic disease of dairy cows that occurs from 0 to 3 days after calving and is characterized by a reduction in serum calcium (Ca) concentration that does not return to normal for several days. Previous studies have reported that the incidence of hypocalcemia in dairy cows is 3.45% in North America, 6 .17% in Europe, and 3.5% in Australia [1] .
Hypocalcemia can be divided into two stages: clinical hypocalcemia (CH) and subclinical hypocalcemia (SH). According to the Merck Veterinary Manual (http://www.merckmanuals. com/vet/), the normal serum Ca concentration in the cow is 2.25 to 2.5 mmol/L, while the Ca concentrations in CH and SH are defined as 0.5 to 1.75 and <2.0 mmol/L, respectively. Hypo calcemia reduces the ability of immune cells to respond to stimuli [2] , thus contributing to the onset of infection, such as mastitis. Furthermore, hypocalcemia reduces smooth muscle contraction, leading to reduced rumen and abomasal motility, resulting in abomasal displacement and reduced feed intake. The effects of hypocalcemia on muscle contraction prevent efficient teat closure, which also contributes to the onset of mastitis [3] . It is well known that Ca concentration is the "gold standard" for the diagnosis of hypocalcemia at 0 to 3 days after calving. Upon diagnosis, cows will rapidly succumb to hypocalcemia, especially CH. In fact, many proteins are known to affect Ca regulation in dairy cows. Shu and Wang reported 12 differentially expressed proteins related to CH and SH by sur faceenhanced laser desorption/ionization timeofflight mass spectrometry [4, 5] .
Proteomics is a relatively new technology in bovine research and is widely used in other areas of research, such as human cancers [6] , plant science [7] , immunology, and parasitology. Twodimensional gel electrophoresis (2DE) coupled with mass spectrometry offers a comprehensive proteomic approach [8] , while fluorescence twodimensional differential gel electrophoresis (2DDIGE) technology adds a quantitative component to con ventional 2DE analyses, allowing for direct comparison of changes in protein abundance across multiple samples simultaneously, with statistical confidence and without interference due to gelto gel variation [9, 10] . Matrixassisted laser desorption/ionizationtime of flight mass spectrometry (MALDI-TOFMS) is often used to identify proteins discovered by 2DDIGE.
Serum samples from healthy dairy cows and those with CH and SH were analyzed by 2DDIGE/MALDITOFMS combined with bioinformatics to identify differentially expressed proteins that affect serum Ca regulation and to elucidate the cause of the reduction in serum Ca concentration after calving and determine why the Ca concentration is not restored to normal for several days after calving.
MATERIALS AND METHODS

Experimental animals
All experimental animals were obtained from an intensive dairy farm in accordance with the requirements of the Veterinary Medical Ethical Committee of the Local Agricultural Department of Mishan, Heilongjiang province, China. All experimental ani mals were maintained in accordance with the International Guiding Principles for Biomedical Research Involving Animals. All cows were fed a total mixed ration (TMR) during the pre partum period, which consisted of 9 kg of concentrated feed, 17 kg of silage maize, 4 kg of hay, and 400 g of fat. The nutritional analysis of the TMR was 55.60% dry matter, 16% crude protein, 5.60% fat, 39.10% neutral detergent fiber, 20.30% acid detergent fiber, and 1.75 mcal/net energy for lactation, 180 g of Ca, 116 g of phosphorus.
Grouping
Blood samples were collected from randomly selected Holstein cows at three time points: 3rd day before calving (day -3), day of calving (day 0), and 3rd day after calving (day +3). None of the cows showed any clinical symptoms on day -3 and diseases other than hypocalcemia on day 0 were excluded. The cows were assigned to one of three groups based on serum Ca concentration on day 0: the CH group (n = 9), obvious clinical symptoms of hypocalcemia and Ca concentration of <1.80 mmol/L; the SH group (n = 9), no clinical symptoms of hypocalcemia and Ca concentrations of 1.80 to 2.00 mmol/L; and a control (C) group (n = 9), no clinical symptoms of hypocalcemia and Ca concen trations of 2.00 to 3.00 mmol/L.
Blood parameter analysis
Blood samples (10 mL) from all tested cows were collected from the caudal vein at three time points in accordance with the Inter national Guiding Principles for Biomedical Research Involving Animals. The samples were centrifuged immediately at 4,000 g for 10 min. Then, the serum fraction was frozen in liquid nitrogen and stored at -80°C until subsequent analyses. The serum Ca concentration was detected using a commercial kit (65156401; Roche Diagnostics, Mannheim, Germany) with an automatic biochemical analyzer (Modular DPP; Roche Diagnostics, Ger many). The serum Ca concentrations at the three time points are shown Figure 1 and group values are shown in Supplementary  Table S1 .
To reduce individual differences, every sample for 2DDIGE was obtained from serum samples of three animals. The test design is depicted in Table 1 and the study strategy is shown in Supplementary Table S2 .
Protein processing
Serum samples were thawed at room temperature and pooled in accordance with the study design. Protein concentrations were measured using the Bradford protein assay. Lysis buffer and 3.5 mg/mL of bovine serum albumin (BSA) at a ratio of 1:3 with ddH 2 O at a ratio of 1:9 with the sample were added to a test tube. A 5μL aliquot of the sample, which was diluted according to the above method, was homogenized in BSA (standard protein buffer) and 875 μL of protein assay buffer (BioRad Laboratories, Inc., Hercules, CA, USA). Protein concentrations were quantified spectrophotometrically at 595 nm with BSA as a standard.
The abundance of albumin and immunoglobulins are varied in serum, and can account for up to 95% of proteins in serum. To increase resolution of the gels, highly abundant proteins were extracted and purified using a protein purification kit (GE Health care, Buckinghamshire, UK), while impurities were removed using a 3kD hyperfiltration tube (UFC800396; Merck Millipore, Billerica, MA, USA), and then centrifuged at 10,000 g for 30 min. All protein concentrations were quantified twice according to the above method.
Fluorescent labelling of proteins
NaOH (50 mmol/L) was added to the samples to adjust the pH to 8.5 and lysis buffer was added to adjust the concentration to 5 mg/mL. The interior label was a mixed liquor of all nine samples and 400 pmol Cy2 fluorescent label was added to every 50 μg of protein in the interior label. The samples were randomly labeled with Cy3 and Cy5. The CH1 sample was added twice to the different gels because of the odd number of total samples. This design was chosen to reduce the occurrence of technical errors and increase replication.
Cy3 and Cy5labeled samples (50 μL) were mixed with the interior label and then twofold buffer (7 M urea, 2 M thiourea, 4% CHAPS (3[{3Cholamidopropyl} dimethylammonio] propan esulfonic acid), 1% BioLyte, pH 3 to 10, 20 mg/mL dithio threitol (DTT) and hydration buffer (7 M urea, 2 M thiourea, 4% CHAPS, 0.5% BioLyte, 10 mg/mL DTT) were added for a final volume of 410 μL.
Two-dimensional gel electrophoresis
Immobiline DryStrips (length, 18 cm; GE Healthcare, UK), containing immobilized ampholytes forming a linear pH gradi ent of 4 to 7, were used for isoelectric focusing (IEF) in the first dimension. The strips were rehydrated in 100 μL of a buffer containing 7 mmol/L urea, 2 mmol/L thiourea, 4% CHAPS, 30 mmol/L Tris buffer, and deionized water. Immobilized pH gradient (IPG) rehydration buffer contained 4.5 mg of 1% DDT, 4.5 μL of 40% ampholyte, and trace amounts of bromophenol blue. The samples were applied to the strips following a cup loading protocol and IEF was performed at room temperature using the IPGPhor IEF system (Amersham Biosciences, Amersham, UK) at 50 V per strip for 13 h, according to the following pro gram: fast gradient at 200 V for 30 min (to remove impurities), linear gradient at 1,000 V for 6 h, focusing at 10,000 V for 60,000 vh, and fast gradient at 500 V to the end of the run.
After IEF, the IPG strips were incubated in equilibration buffer I (6 mol/L urea, 20% glycerol, 2% sodium dodecyl sulfate (SDS), 0.375 mol/L TrisHCl, 0.1 g DDT) while shaking for 15 min, and then in equilibration buffer II (buffer I in which DTT was replaced by 0.4 g iodoacetamide) for a further 15 min. Thereafter, the strips were individually applied to the surface of a vertical 12% poly acrylamide gel and sealed with 0.5% agarose dissolved in electro phoresis buffer (3 g Trisalkali, 14.4 g of glycerol, 0.1% SDS) with traces of bromophenol blue. SDSpolyacrylamide gel electrophoresis (PAGE) Broad Range or All Blue Precision Plus Protein (BioRad Laboratories, Inc., USA) molecular weight standards were loaded at each end of the strip. Seconddimen sion electrophoresis was performed using an EttanDALT II gel at a constant gain of 30 V for 60 min, then 80 V for 16 h.
Gel scanning and analysis
Following electrophoresis, signals from the three fluorophores in each gel were sequentially scanned using a Typhoon 9410 fluorescence imager (GE Healthcare, UK). The corresponding excitation and emission wavelengths for Cy3 and Cy 5 were 532 and 580 nm, and 633 and 670 nm, respectively. Cy2 images were obtained at wavelengths of 488 and 520 nm. The DeCyder (V6.5) was used for analysis of the DIGE gel to determine differences in protein content. The ttest was used to identify significant differences in protein expression. A probability (p) value of ≤0.05 and an increase in expression of >1.5fold were considered stati stically significant.
Mass spectrometry analyses and database search for protein identification
According to the results of the second protein quantification, the preparation gel, which was used for MS, was used for all samples according to the abovementioned method. The analysis gel, which was used to determine differences in protein expres sion, was used to compare the preparations to ensure the places of proteins exhibiting differences in expression profiles. Then, spots containing proteins were carefully excised using a scalpel. After freezedrying, the spots were mixed with trypsin solution and then subjected to enzymolysis at 37°C in a water bath for Interior label CH3 C3 Gel 5
Interior label SH3 CH2
1) The regulation of labeled is that sample of every group was not labeled only one kind fluorescence.
2) "Interior label" is pooled all samples for reducing the individual difference. "CH1, CH2, CH3" are three samples in clinical hypocalcemia group. "SH1, SH2, SH3" are three samples in subclinical hypocalcemia group. "C1, C2, C3" are three samples in control group.
16 h. Before MS analysis, peptides were extracted by the addition of 5% trifluoroacetic acid (TFA) solution. Then, 0.5 μL of each peptide sample was placed on target of the mass spectrograph. After addition of 5 mg/mL of matrix solution (αcyan4hydroxy cinnamic acid, 0.1% TFA, 50% acetonitrile), the peptide samples were analyzed by MALDI-TOF MS using an ABI4800 mass spectrometer (Applied Biosystems, Foster City, CA, USA) under the following parameters: scanning mode, reflectiontype; range, 700 to 4,000 Da; laser energy of full scan, 5,000; second scan, 5,500. All proteins were identified by a search of the National Center for Biotechnology Information (NCBI) database.
Bioinformatics analysis
Gene ontology (GO) analysis is an important analytical method in bioinformatics software for highthroughput data. Cytoscape (http://www.cytoscape.org/) is an open source software platform for analysis of highthroughput data. The many plugins with Cytoscape are used for GO analysis and prediction of protein structure, and so on. In this study, the Bin/GO tool, a plugin of Cytoscape (version 2.8.3), was used for GO analyses. All identified proteins were used for pathway analysis with the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (http://www.genome.jp/kegg/).
Western blot analysis
The MS results showed that expression of the alpha2macro globulin (A2M) protein was upregulated in the CH group and downregulated in the SH group, as compared with the C group. To verify the results of 2DDIGE/MALDITOFMS, differentially expressed proteins were chosen for western blot (WB) analysis using rabbit antiA2M antibody (bs9505R; Bioss, Inc., Woburn, MA, USA).
Crude serum proteins from three groups (CH group, n = 3; SH group, n = 2; C group, n = 3) at day -3 before calving were used for WB analysis. Equal amounts of proteins were separated by 5% to 20% SDSPAGE and transferred to polyvinylidene fluoride membranes. After blocking with 5% skim milk powder for 2 h at 37°C, target proteins were incubated with primary antibodies for 2 h while shaking overnight at 4°C. Then, the membranes were incubated with secondary antibodies overnight at 4°C. Afterward, the membranes were dried to form a gel for scanning. The A2M protein content of the three groups was ana lyzed to verify relative expression levels.
RESULTS
Change in Ca concentrations from before calving to after
The Ca concentrations of the samples are shown in Figure 1 . All data are provided in Supplementary Table S1 . The Ca con centrations of all three groups were decreased on day 0, and there were no significant difference on day -3. Although the Ca con centrations of three groups were decreased on day 0, that of the C group was still in the normal range. The Ca concentration in the C group was restored to a normal range on day +3, but not the other two groups, especially the CH group.
Analysis of differential protein expression
A representative fluorescent image is shown in Figure 2 . All images are provided in Supplementary Table S3 . Fiftyseven protein spots were separated. Each of these protein spots was significantly different between at least two groups (1.5fold difference in abundance; p<0.05). Twentyseven spots were selected for MALDI TOFMS, each spot on the gel was required not to be connected to any other spot, and the blot was clear and complete.
Mass spectrometry identification of differentially expressed proteins
Thirteen peptide mass fingerprints (PMFs) of 27 spots were ob tained after MALDI-TOFMS identification. The NCBI database was searched to identify the 13 PMFs to confirm the identification of the proteins. Of the 13 PMFs, eight different proteins were identified.
The results of MS analysis are shown in Table 2 . The eight differentially expressed proteins included third party data (TPA): vitamin Dbinding protein precursor (GC), complement C4 precursor (C4), paraoxonase 1 (PON1), A2M, endopin 1 (EN1), TPA: apolipoprotein AIV precursor (APOA4), alpha1anti trypsin, and haptoglobin (HP). Bioinformatics analysis of differentially expressed proteins Gene ontology analysis: All differentially expressed proteins were analyzed using the BinGO plugin of the Cytoscape software. As shown in Supplementary Table S4, there were 150 and 24 annotations to the molecular function and biological process, respectively. Considering that a given protein can be attributed to several functions and/or processes, the annotations of biological processes and molecular functions were filtrated, which were related with hypocalcemia ( Figure 3 ). "Steroid metabolic process", and "Vitamin D metabolic process" were the most represented biological processes. "Vitamin D binding", "Vitamin transporter activity", and "Protein binding" were the most represented mol ecular functions.
Pathway analysis: The KEGG Pathway database was used to search for all differentially expressed proteins. Four proteins, A2M, GC, C4, and APOA4, were identified in five pathways which may be related with hypocalcemia, including the "Endocrine and other factorregulated Ca reabsorption" (ID: 04961), "Mineral absorption" (ID: 04978), "Complement and coagulation cascades" (ID: 04611), "Fat digestion and absorption" (ID: 04975) and "Vitamin digestion and absorption" (ID: 04977) ( Table 3) .
Since so many pathways were found related to different proteins, all results were analyzed, filtered, and integrated. An integrated pathway to explain the relationship between the differ entially expressed proteins and serum Ca regulation is shown in Figure 4 . In summary, GC is an important factor in many pathways. GC specifically binds with vitamin D 3 (VD 3 ) in small intestinal epithelial cell and distal convoluted tubular (DCT) cells, and then promotes Ca 2+ binding with the Cabinding protein (CBP) in order to transfer Ca 2+ to the blood. In addition, if there is an insufficient amount of GC specific binding with VD 3 , in small intestinal epithelial cells, VD 3 with APOA4 enter the chylo micron, then the chylomicron is exocytosed to the extracellular space and finally enters the blood via lymph transfer.
Western blot analysis
The expression levels shown in Figure 5 were calculated as the ratio among the three groups. All data are shown in Supplementary  Table S5 . A2M expression was increased (CH/C: 6.10%) in the CH group and reduced (SH/C: 15.53%) in the SH group. The WB analysis strongly supported the results of 2DDIGE com bined with MALDI-TOFMS.
DISCUSSION
In this study, eight types of proteins were found among the three Vitamin digestion and absorption APOA4 1) GC, vitamin D-binding protein precursor; A2M, α-2-macroglobulin; C4, complement C4 precursor; APOA4, apolipoprotein A-IV precursor. groups via 2DDIGE/MALDITOFMS. Of these, bioinformatics analysis indicated that GC and A2M were relative to hypocal cemia. A2M was chosen for western blotting analysis based on the results of DIGE/MALDITOFMS and bioinformatics analysis.
Potential pathogenesis of clinical hypocalcemia
In this study, the serum Ca concentrations of all cattle decreased on day 0, which was consistent with the results of previous studies [11, 12] . This decrease likely resulted from providing nutrition to the fetus and formation of the beestings. Mechanisms are in place to efficiently maintain normal serum Ca concentration most of the time, but occasionally these homeostatic mechanisms fail, which results in hypocalcemia [3] . Physiologically, hormones, including calcitonin (decreases Ca concentration), parathyroid hormone (PTH, increases Ca concentration), and 1,25dihy droxyvitamin D 3 (1,25(OH) 2 D 3 , increases Ca concentration), act to control Ca metabolism [1] . 1,25(OH) 2 D 3 is required to stimulate the intestine to absorb dietary Ca. This hormone is produced in the kidney from vitamin D [13] . About 85% of se rum 1,25(OH) 2 D 3 binds with high affinity to GC [14] . GC is a 55kDa protein that is a member of the albumin superfamily and is secreted by the liver. One of the physiological functions of the GC protein is vitamin D transport and storage [15] . According to the results of this study, GC was downregulated in the CH group, as compared with the C and SH groups, while there was no significant difference between the C and SH groups. As a potential pathogenesis of CH, GC was reduced before calving. When the serum Ca concentration was decreased on calving day, the amount of GC is insufficient to combine with vitamin D. Thus, the role of vitamin D was inhibited leading to a severe decrease in serum Ca concentration. Ca is continually consumed by providing nutrition to the fetus and forming the beestings, which prevents restoration of serum Ca to normal concentrations. Another surmise was that APOA4, a 46kDa highdensity lipoprotein (HDL), is secreted from the small intestine in response to lipid absorption and chylomicron formation [16] . It is reg ulated by leptin, a major component of energy homeostasis [17] . The integrated pathway ( Figure 5) shows that ApoA4 enters the circulation on lymph chylomicrons and is subsequently released as a lipidfree protein during lipolysis of chylomicrons [18] . Haas and Mooradian [19] reported that vitamin D levels were positively correlated with plasma HDL levels, but inversely with plasma lowdensity lipoprotein cholesterol levels. The result of this study showed that APOA4 was downregulated in the CH group, as compared with the C and SH groups, while there was no significant different between the C and SH groups. An addition physiological function of the GC protein is VD 3 storage. In summary, serum APOA4 levels may be affected by Ca regul ation and may be positively correlated with GC expression.
Early detection index of hypocalcemia
In this study, the A2M protein was detected by 2DDIGE/MALDI TOFMS and verified by WB analysis. A2M expression was upregulated in the CH group and downregulated in the SH group, as compared with controls. Wang et al [20] reported that A2M plays a role in osteoarthritis and suggested that A2M is a powerful inhibitor of many cartilage catabolic factors through protease activities. A2M inhibits cartilage catabolic factor through decreased gene expression to protect the cartilage. In addition, tartrateresistant acid phosphatase (TRACP) 5b is derived from osteoclasts, which circulate in large complexes that contain A2M and Ca [21] . Many reports have suggested that serum TRACP 5b is a specific and sensitive marker of bone restoration that can be used for the diagnosis and followup of skeletal pathologies [22] . Boneresorbing osteoclasts contain high amounts of TRACP 5b and secrete it into the bloodstream.
This evidence suggests that A2M expression is related to Ca concentration. Although the relationship between A2M and Ca remains unclear, A2M was useful as an early detection index to distinguish CH from SH from healthy dairy cows before calving. However, further studies are needed to elucidate the underlying mechanisms.
Other proteins related to hypocalcemia
Other proteins identified in this study included PON1, C4, HP, EN1, and AAT. PON1 is a 44kDa glycoprotein that hydrolyzes organophosphates found in pesticides, neurotoxins, and arylesters [22, 23] . PON1 is synthesized mainly in the liver, with lower expression found in the lungs, heart, brain, kidneys, and small intestine [24] . The results of 2DDIGE/MALDITOFMS showed that PON1 expression was downregulated in the CH group, as compared with the SH and C groups, respectively. A possible mechanism for the effects of PON1 is the upregulation of PTH receptor 1, as described by Lu et al [25] . PTH is an important hormone for the balance of Ca and P. Since the PTH receptor 1 specifically binds to PTH, the level of PTH receptor 1 is positively correlated with the level of PTH, suggesting that PON1 affects serum Ca concentration via the PON1 receptor 1 and available PTH.
C4 activation acts as immune surveillance system in healthy and altered host cells to detect the presence of foreign matter. C4 is a component of C3 convertase in the classical and lectin complement pathways, which is expressed in two polymorphic isotypes, C4A and C4B [26] .
HP is primarily produced in the liver and is functionally im portant for binding free hemoglobin from lysed red cells in, preventing its toxic effects [27] . Decreased HP is a marker of hemolysis, as HP levels become depleted in the presence of large amounts of free hemoglobin [28] .
EN1 is present in endorine tissues, as specified by "endo" and its serpinlike characteristic indicated by "pin", thus designating this new serpin as endopin 1. EN1 is present within isolated chromaffin granules, secreted from chromaffin cells in culture, and inhibits trypsin and plasmin via cleavage at basic residues [29] .
AAT is a 52kD glycoprotein produced mainly by hepatocytes and secreted into the blood. AAT deficiency is a rare genetic dis order associated with the development of liver and lung diseases [30] .
In summary, the results of this study identified several proteins associated with hypocalcemia, although this evidence could also explain other diseases that often occur during and after calving caused by hypocalcemia, including fatty liver (AAT, C4) and endometritis (HP, C4).
In this study, 2DDIGE/MALDITOFMS, bioinformatics, and western blotting were performed to distinguish healthy cows from those with CH and SH. A total of eight differentially expressed proteins were identified among the three groups. Due to its specific expression, A2M was selected for validation, and results show that it was as an early detection index. The possible pathogenesis of CH caused by GC and APOA4 was speculated. Further eval uation of these findings is required for clinical translation.
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